Access cutting-edge hiv infection treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access hiv infection specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv infection treatment provided free
This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 weeks to \<12 years and weighing \<45 kg, who are treatment-naive (TN) or have been virologically suppressed (VS) on stable combination antiretroviral therapy (cART) for ≥3 months with no history of treatment failure. The first primary objective is to evaluate the steady state pharmacokinetics (PK) of doravirine (DOR) \[MK-1439\] when given in combinat
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this hiv infection clinical trial in Atlanta, GA
If you're searching for hiv infection treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.